Related Experiment Video
Updated: Jan 24, 2026

Digital-Droplet PCR to Detect Indels Mutations in Genetically Modified Anopheline Mosquito Populations
Published on: June 28, 2021
Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays
Xi-Wen Jiang1, Wei Liu2, Xiao-Ya Zhu1
1Da An Gene Co., Ltd. of Sun Yat‑sen University, Guangzhou, Guangdong 510665, P.R. China.
Abstract:
Targeted drugs have been widely used in the treatment of patients with lung cancer, particularly for those with non‑small cell lung cancer (NSCLC). Plasma cell‑free DNA is an emerging clinical tool for the detection of epidermal growth factor receptor (EGFR) gene mutation in patients with lung cancer. Detection of circulating tumor (ct) DNA by droplet digital PCR (ddPCR) is a highly sensitive and minimally invasive alternative for the assessment and management of cancer. In the present study, four ddPCR systems were developed to detect the 19DELs, L858R, T790M and C797S mutations of the EGFR gene in plasma ctDNA samples, and all exhibited higher sensitivity compared with the amplification refractory mutation system (ARMS)‑PCR assays. The results revealed that the sensitivity of the ddPCR assays for the four major types of EGFR mutant reached 0.04%. In total, 50 plasma ctDNA samples were collected from patients with NSCLC to detect the 19DELs, L858R, T790M and C797S mutations by ddPCR and ARMS‑PCR. All the mutations except for C797S were detected and the concordance rates between ddPCR and ARMS‑PCR were 96% (19DELs), 98% (L858R) and 100% (T790M). The fraction of EGFR mutation ranged from 0.43 to 68.07% using the ddPCR method. Therefore, the present study suggests that the four ddPCR testing systems could be used for early detection of EGFR mutations in plasma samples, so that patients can better select the targeted drugs according to the EGFR mutation.
Insights
New droplet digital PCR (ddPCR) tests offer highly sensitive detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) plasma cell-free DNA (cfDNA). This minimally invasive approach aids in early diagnosis and personalized targeted drug selection for lung cancer patients.
Area of Science:
- Molecular Oncology
- Genetics
- Biotechnology
Background:
- Targeted therapies are crucial for non-small cell lung cancer (NSCLC), often guided by epidermal growth factor receptor (EGFR) gene mutations.
- Plasma cell-free DNA (cfDNA) analysis offers a minimally invasive method for detecting cancer mutations.
- Droplet digital PCR (ddPCR) is a highly sensitive technique for analyzing cfDNA.
Purpose of the Study:
- To develop and evaluate four ddPCR systems for detecting key EGFR mutations (19DELs, L858R, T790M, C797S) in NSCLC patient plasma cfDNA.
- To compare the sensitivity and concordance of ddPCR assays against traditional amplification refractory mutation system (ARMS)-PCR.
Main Methods:
- Development of four specific ddPCR assays targeting EGFR mutations: 19DELs, L858R, T790M, and C797S.
- Analysis of 50 NSCLC plasma cfDNA samples using both the developed ddPCR systems and ARMS-PCR.
- Assessment of assay sensitivity, reaching as low as 0.04% for EGFR mutations, and calculation of concordance rates.
Main Results:
- The ddPCR assays demonstrated significantly higher sensitivity compared to ARMS-PCR.
- Concordance rates between ddPCR and ARMS-PCR were high: 96% for 19DELs, 98% for L858R, and 100% for T790M.
- The fraction of EGFR mutations detected by ddPCR ranged from 0.43% to 68.07%.
Conclusions:
- The developed ddPCR testing systems are highly sensitive and suitable for early detection of major EGFR mutations in plasma cfDNA.
- These ddPCR assays provide a reliable, minimally invasive tool for NSCLC patient management.
- Enables timely selection of appropriate targeted therapies based on precise EGFR mutation status.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
PCR
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms

